Abstract Submission is Open!

We invite you to participate in the 22nd International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, to be held in Banff, Canada, September 15-18, 2024. The theme of the congress is "Exploring New Frontiers in TDM and Toxicology".

Registration will open next week!

IMPORTANT DATES

• March 31, 2024: Abstract submission deadline – Submit Now!
• March 31, 2024: Breakfast Roundtable proposal deadline
• May 15, 2024: Abstract acceptance notification
• June 30, 2024: Early Registration discount deadline
• September 15-18, 2024: Congress days

Congress Chairs:
Penny Colbourne and David Kinniburgh

Congress website: iatdmct2024.org

Contact Us: info@iatdmct2024.org

TRAVEL GRANTS

A limited number of International Travel Grants are available to help offset travel expenses to attend the IATDMCT Congress. Click here for full details and the application form.

This year, some additional grant funding may be provided to members from developing countries. Please ensure to submit all required documents as outlined on the application form &endash; incomplete applications will not be eligible.

Find the latest news and follow our IATDMCT institutional page on LinkedIn, X(Twitter) @IATDMCT or Instagram!

This month we hear from Paul Chin and Marie-Claire Morahan, who recently contributed this piece to our newsletter Compass (on behalf of the Anti-infective Drugs Committee). Paul and Marie-Claire present three cases illustrating some very common challenges that arise when using dose forecasting software for vancomycin. What would you do next in these cases?

The Editors of Therapeutic Drug Monitoring are delighted to announce the work on a Special Issue on TDM of Immunosuppressive drugs for the year 2024. The Special Issue will be developed in collaboration with the Immunosuppressive Drugs Scientific Committee IATDMCT. Dr. Florian Lemaitre will be Co-Editor.

Review articles and original research related to the focus of the Special Issue are appropriate. If you are interested to submit innovative work from your research group, please send your proposals to the Review Editor, Dr. Shipkova at maria.shipkova@arcor.de. After Dr. Shipkova’s approval, you should submit the article online. The deadline for the submissions is July 30.

Stay ahead with the latest scientific research developments in the fields of TDM and CT!

The monthly Therapeutic Drug Monitoring column provides you with the latest posts of ahead-of-print. Bringing to you articles posted online January 1 – February 9, 2024:

ORIGINAL ARTICLES:

• Analytical Validation of a Volumetric Absorptive Microsampling Method for Therapeutic Drug Monitoring of the Oral Targeted Anticancer Agents, Abiraterone, Alectinib, Cabozantinib, Imatinib, Olaparib, and Sunitinib, and Metabolites
  Meertens, Marinda; de Vries, Niels; Rosing, Hilde; Steeghs, Neeltje; Beijnen, Jos H.; Huitema, Alwin D. R.
  January 30, 2024
• Changes in Psychotropic Drug Concentrations Across the Menstrual Cycle: A Pilot Study
  Spadi, Julia; Scherf-Clavel, Maike; Leutritz, Anna Linda; Hütz, Barbara; Matentzoglu, Maria; Nieberler, Matthias; Kurlbaum, Max; Hahner, Stefanie; Bartmann, Catharina; McNeill, Rhiannon V.; Kittel-Schneider, Sarah
  January 30, 2024
• Fluorescence-Based Lateral Flow Immunoassay for Quantification of Infliximab: Analytical and Clinical Performance Evaluation
  Kim, Eun Sil; Chon, Hyangah; Kwon, Yiyoung; Lee, Misook; Kim, Mi Jin; Choe, Yon Ho
  January 26, 2024
• Novel Identification of Cysteinyl Derivatives of Toxic Clozapine Nitrenium Ions and the Effect of Valproic Acid on Metabolite Formation: A Study Using Reprocessed High-Resolution Mass Spectra of Analyzed Therapeutic Drug Monitoring Samples
  Wollmann, Birgit M.; Haugen, Aina G.; Smith, Robert L.; Molden, Espen
  January 26, 2024
• Factors Influencing Plasma Concentrations of Valproic Acid in Pediatric Patients with Epilepsy and the Clinical Significance of CYP2C9 Genotypes in Personalized Valproic Acid Therapy
  Ma, Bingsuo; Yang, Kun; Li, Xinping; Su, Ning; Yu, Ting; Zou, Yan; Xu, Xingmeng; Wang, Fei; Cheng, Jingdong; Yan, Zijun; Chen, Tong; Zhang, Liangming
  January 26, 2024
• Analysis of Factors Affecting Concentrations and Concentration-To-Dose Ratios of Trazodone
  Song, Yang; Chang, Luyao; Lun, Yang; Chen, Chaoli; Fu, Ran; Wang, Donghan; Zhou, Chunhua
  January 26, 2024
• A Validated Assay to Quantify Osimertinib and Its Metabolites, AZ5104 and AZ7550, from Microsampled Dried Blood Spots and Plasma
  Venkatesh, Bharat; Yuile, Alex; McKay, Matthew J.; Narayanan, Sathya; Wheeler, Helen; Itchins, Malinda; Pavlakis, Nick; Clarke, Stephen J.; Molloy, Mark P.
  January 24, 2024
• Predictive Performance of a Gentamicin Pharmacokinetic Model in Term Neonates with Perinatal Asphyxia Undergoing Controlled Therapeutic Hypothermia
  van der Veer, Marlotte A. A.; de Haan, Timo R.; Franken, Linda G. W.; Groenendaal, Floris; Dijk, Peter H.; de Boode, Willem P.; Simons, Sinno; Dijkman, Koen P.; van Straaten, Henrica L.M.; Rijken, Monique; Cools, Filip; Nuytemans, Debbie H. G. M.; van Kaam, Anton H.; Bijleveld, Yuma. A.; Mathôt, Ron A. A.; for the PharmaCool Study Group
  January 24, 2024
• Development, Validation, and Clinical Application of an Ultra–High-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry Method for the Determination of 10 Antituberculosis Drugs in Human Serum
  Fan, Xudong; Guo, Suhang; Zhang, Ruoying; Cai, Qingshan; Lang, Yazhen; Huang, Jinpeng; Chen, Yuanyuan; Zhang, Ying; Xu, Yingying; Chen, Meng; Yang, Gaoyi; Cai, Xinjun
  January 24, 2024

REVIEW ARTICLE:

• Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants
  Hart, Xenia M.; Spangemacher, Moritz; Defert, Julie; Uchida, Hiroyuki; Gründer, Gerhard
  January 24, 2024

SHORT COMMUNICATION:

• Tocilizumab Dose Tapering Based on a Model-Based Algorithm is Feasible in Clinical Practice: A Short Communication
  Hooijberg, Femke; Layegh, Zohra; Leeuw, Maureen; Boekel, Laura; van den Berg, Stefan P.H.; Ruwaard, Jill; Bastida, Carla; Huitema, Alwin D.R.; Pel, Sara; Elkayam, Ori; de Vries, Annick; Nurmohamed, Mike; Rispens, Theo; Dorlo, Thomas P.C.; Wolbink, Gertjan
  January 24, 2024

LETTERS TO THE EDITOR:

• A Short Turnaround of Clozapine Blood Level Results Within 6 hours is Essential for Effective Management of Severely Ill Persons with Treatment-Resistant Schizophrenia
  Vincent, Philippe D.; Lesage, Alain; Lalonde, Pierre; Lipp, Olivier; De Guire, Vincent; Desbiens, Marie-Pierre; Schoretsanitis, Georgios
  February 9, 2024
• Crying Over Stark Differences: Resource Disparity and Therapeutic Drug Monitoring
  Carland, Jane E.; Stojanova, Jana; Lau, Cindy; Day, Richard O.; Marriott, Deborah J.E.
  February 1, 2024

CASE REPORT:

• Unveiling the Rare Presentation of Acetylsalicylate Overdose: Grand Round
  Kohara, Saeko; Kamijo, Yoshito; Kyan, Ryoko; Hishikawa, Tsuyoshi; Okada, Ichiro; Hasegawa, Eiju
  February 6, 2024

››Submit your high quality research – Information for authors.

We are delighted to announce that our Renewed Website is On-line!

https://iatdmct.org/

We are thrilled to announce the new website! The information most relevant to you. It is also fully responsive with mobile devices, making it easy to navigate on a wide range of web browsers and portable devices. We will be updating our content with helpful information, articles, blogs, newsletters, podcasts, announcements, in the News section.

We hope you find the new website, easy to access information. We also wish to establish this portal as a source of information for those who visit our site. Please, e-mail your questions, sugestiones, or comments. We also are open to advertise laboratory and academic positions, doctoral and postdoctoral fellowship positions.

We are inviting members interested to join Communication Committee to assist in the management of Social Media (Twitter and Website).

Please send an email to Dr. Ofelia Noceti (ofelianp@gmail.com) and Dr. Ryuji Kato (ryuji.kato@ompu.ac.jp), which includes a resume or CV and explanatory note telling which area you would like to be involved in. We are looking forward to your applications!

» Click here to Post an Event on our Online Events Calendar today!

Visit the IATDMCT Events Calendar and stay informed about the upcoming TDM and CT Meetings. By doing this you can comfortably and directly reach all related online resources.

The International Congress of Pediatric Laboratory Medicine (ICPLM) is the triennial meeting of the Task Force on Pediatric Laboratory Medicine (TF-PLM) of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). The focus of the congresses are the latest scientific and technological achievements in all areas of pediatric clinical and diagnostic laboratory medicine. The meeting now takes place immediately before the IFCC World Lab. The congress offers you the unique opportunity to gather the latest information in laboratory medicine for children as well as for adult patients.

Dr. Manuela Neuman invites you to:

The 15th Annual Charles Lieber Memorial Satellite
Alcohol, Cannabis, Covid, Microbiome, Age, & Chronic Diseases

9:00-13:40, Sunday, June 23, Minneapolis, MN, USA

Organizers:
Manuela G. Neuman M.Sc., Ph.D., FCACB
manuela.neuman@rogers.com
University of Toronto, Toronto, Canada

Helmut Karl Seitz, M.D.
helmut_karl.seitz@urz.uni-heidelberg.de
University of Heidelberg, Heidelberg, Germany

This satellite is dedicated to Charles S. Lieber, who was a pioneer in the field of alcohol-induced liver and gastrointestinal diseases. Dr. Lieber has been a clinical investigator, physician and passionate academic teacher. Dr. Lieber’s groundbreaking contributions to the field of alcohol-induced liver damage is unique by introducing the cytochrome P450 2E1. He was a devoted clinician as well as mastering research areas including hepatic cirrhosis and fibrosis. His outstanding contribution in clinical research is unparalleled. He treated patients for 50 years.

The symposium will address the following: mechanisms and biomarkers of alcohol-induced damage to different organs, as well as the role of other substances of misuse in this dialogue. Participants will learn about the relationship between alcohol intake in several chronic diseases, in the presence or absence of COVID-19 and viruses, as well as the interactions of alcohol with medications and drugs of misuse. Conversely, participants will also learn about alcohol consumption on metabolic diseases. Please contact Manuela Neuman for details.

Congress website: iatdmct2024.org

Contact Us: info@iatdmct2024.org

Co-editor: Manuela Neuman
Co-editor: Ryuji Kato
Co-editor: Miao Yan

NOTE: Items appearing in the IATDMCT monthly E-News do not necessarily have the endorsement of the Association.